1. Home
  2. KRO vs KALV Comparison

KRO vs KALV Comparison

Compare KRO & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

HOLD

Current Price

$6.38

Market Cap

730.6M

Sector

Industrials

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$19.27

Market Cap

757.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRO
KALV
Founded
1916
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
730.6M
757.7M
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
KRO
KALV
Price
$6.38
$19.27
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
2
5
Target Price
$6.00
$32.60
AVG Volume (30 Days)
379.1K
931.8K
Earning Date
03-09-2026
03-25-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,859,400,000.00
$50,000,000.00
Revenue This Year
$3.47
$122.34
Revenue Next Year
$11.59
$99.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
495.66
52 Week Low
$4.08
$9.83
52 Week High
$7.90
$19.27

Technical Indicators

Market Signals
Indicator
KRO
KALV
Relative Strength Index (RSI) 63.28 67.38
Support Level $5.89 $14.66
Resistance Level $6.74 N/A
Average True Range (ATR) 0.33 1.25
MACD 0.14 0.20
Stochastic Oscillator 88.28 87.65

Price Performance

Historical Comparison
KRO
KALV

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: